Use of breast-conserving surgery is not recommended, as TP53 mutation carriers are more susceptible to radiation-induced DNA damage and are more likely to develop radiation-associated cancers such as angiosarcoma [23]. This evidence concerns the gene TP53 and angiosarcoma.